|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Mirum Pharmaceuticals, Inc. (MIRM) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
53,602,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mirum Pharmaceuticals is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of therapies for rare and orphan diseases. Co.'s focus is the development and commercialization of LIVMARLI® (maralixibat) oral solution (Livmarli) and volixibat. Livmarli is an oral solution approved as a once daily medicine for cholestatic pruritus in patients with Alagille syndrome one year of age and older. Co.'s second product candidate, volixibat, an oral, minimally-absorbed agent designed to inhibit ileal bile acid transporter, for the treatment of adult patients with cholestatic liver diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,000 |
4,000 |
175,963 |
175,963 |
| Total Buy Value |
$101,200 |
$101,200 |
$4,703,025 |
$4,703,025 |
| Total People Bought |
1 |
1 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
8 |
8 |
| Total Shares Sold |
4,303 |
26,974 |
69,916 |
431,922 |
| Total Sell Value |
$111,017 |
$737,972 |
$1,983,116 |
$9,495,201 |
| Total People Sold |
1 |
5 |
6 |
8 |
| Total Sell Transactions |
1 |
12 |
21 |
30 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Florence Anthony A. Jr. |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| Chang Carmen |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
135 |
|
- |
|
| Chang Carmen |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| Chang Carmen |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
|
- |
|
| Makhzoumi Mohamad |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
41,501 |
11,348 |
|
- |
|
| Makhzoumi Mohamad |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| Walker Paul Edward |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,114 |
114 |
|
- |
|
| Walker Paul Edward |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2023-06-08 |
4 |
AS |
$29.00 |
$423,632 |
D/D |
(14,608) |
0 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2023-06-08 |
4 |
OE |
$2.94 |
$42,889 |
D/D |
14,608 |
14,608 |
|
- |
|
| Vig Pamela |
Head of Research & Development |
• – – |
2023-05-10 |
4 |
A |
$16.92 |
$11,576 |
D/D |
684 |
32,211 |
|
- |
|
| Radovich Peter |
Chief Operating Officer |
• – – |
2023-05-10 |
4 |
A |
$16.92 |
$16,382 |
D/D |
968 |
39,100 |
|
- |
|
| Longpre Lara |
Chief Development Officer |
• – – |
2023-05-10 |
4 |
A |
$16.92 |
$11,576 |
D/D |
684 |
106,843 |
|
- |
|
| Peetz Christopher |
President and CEO |
• • – |
2023-05-10 |
4 |
A |
$16.92 |
$21,256 |
D/D |
1,256 |
120,832 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2023-05-03 |
4 |
AS |
$28.00 |
$409,024 |
D/D |
(14,608) |
0 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2023-05-03 |
4 |
OE |
$2.94 |
$42,889 |
D/D |
14,608 |
14,608 |
|
- |
|
| Howe Jolanda |
SVP, Global ControllerOfficer |
• – – |
2023-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,769 |
|
- |
|
| Radovich Peter |
Chief Operating Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,440 |
38,132 |
|
- |
|
| Peetz Christopher |
President and CEO |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
119,576 |
|
- |
|
| Longpre Lara |
Chief Development Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,625 |
106,159 |
|
- |
|
| Vig Pamela |
Head of Research & Development |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,625 |
31,527 |
|
- |
|
| Longpre Lara |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-01-09 |
4 |
S |
$20.62 |
$20,684 |
D/D |
(1,003) |
104,369 |
|
- |
|
| Vig Pamela |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-01-09 |
4 |
S |
$20.62 |
$28,438 |
D/D |
(1,379) |
27,312 |
|
- |
|
| Peetz Christopher |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-09 |
4 |
S |
$20.62 |
$106,390 |
D/D |
(5,159) |
91,953 |
|
- |
|
| Radovich Peter |
PRESIDENT AND COO |
• – – |
2023-01-09 |
4 |
S |
$20.62 |
$28,438 |
D/D |
(1,379) |
33,316 |
|
- |
|
191 Records found
|
|
Page 3 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
